PORTE TORRE, LORENA ISABEL
Thumbnail Image
Preferred name
PORTE TORRE, LORENA ISABEL
Main Affiliation
Email
lporte@udd.cl
ORCID

Research Output

2023 2023 2022 2022 2021 2021 2020 2020 2019 2019 2018 2018 2017 2017 2016 2016 2015 2015 2014 2014 0 0 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8

Filters

36
Reset filters

Settings
Now showing 1 - 10 of 36
No Thumbnail Available
Publication

Catheter-associated bloodstream infection caused by Leifsonia aquatica in a haemodialysis patient: a case report

2012 , Lorena Porte , Andrés Soto , Daniela Andrighetti , Jeannette Dabanch , Stephanie Braun , Alejandra Saldivia , Juan Carlos Flores , Aniela Wozniak , Patricia García , WEITZEL, THOMAS

View
No Thumbnail Available
Publication

Evaluation of antimicrobial susceptibility testing directly from positive blood cultures using the Vitek 2 system: comparison of two rapid protocols

2017 , Lorena Porte , Francesca Gattini , Carmen Varela , Thomas Wettzel

View
No Thumbnail Available
Publication

Cryptococcus bacillisporus (VGIII) Meningoencephalitis Acquired in Santa Cruz, Bolivia

2021 , THOMPSON MOYA, LUIS ADALBERTO , PORTE TORRE, LORENA ISABEL , DIAZ TAPIA, VIOLETA DEL CARMEN , María Cristina Díaz , Sebastián Solar , Pablo Valenzuela , Nicole Norley , Yumai Pires , Fernando Carreño , Sergio Valenzuela , Rukmane Shabani , Volker Rickerts , WEITZEL, THOMAS

We describe a case of chronic meningoencephalitis with hydrocephalus caused by Cryptococcus bacillisporus (VGIII) in an immunocompetent patient from Santa Cruz, Bolivia. This first report of a member of the Cryptococcus gattii species complex from Bolivia suggests that C. bacillisporus (VGIII) is present in this tropical region of the country and complements our epidemiological and clinical knowledge of this group of emerging fungal pathogens in South America.

View
No Thumbnail Available
Publication

Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey

2020 , WEITZEL, THOMAS , Fernanda Rodríguez , Luis Miguel Noriega , Alejandra Marcotti , Luisa Duran , Carla Palavecino , Lorena Porte , AGUILERA SANHUEZA, XIMENA PAZ , Marcelo Wolff , Claudia P. Cortes , Yury E. Khudyakov

View
No Thumbnail Available
Publication

Corynebacterium kroppenstedtii

2012 , PORTE TORRE, LORENA ISABEL , WEITZEL, THOMAS

View
No Thumbnail Available
Publication

Head-to-head comparison of CAMPYAIR aerobic culture medium versus standard microaerophilic culture for Campylobacter isolation from clinical samples

2023 , Arturo Levican , Carmen Varela , Lorena Porte , WEITZEL, THOMAS , Isabel Briceño , Francisco Guerra , Benjamín Mena , Arthur Hinton

Campylobacter spp. are considered the most frequent cause of acute gastroenteritis worldwide. However, outside high-income countries, its burden is poorly understood. Limited published data suggest that Campylobacter prevalence in low- and middle-income countries is high, but their reservoirs and age distribution are different. Culturing Campylobacter is expensive due to laboratory equipment and supplies needed to grow the bacterium (e.g., selective culture media, microaerophilic atmosphere, and a 42°C incubator). These requirements limit the diagnostic capacity of clinical laboratories in many resource-poor regions, leading to significant underdiagnosis and underreporting of isolation of the pathogen. CAMPYAIR, a newly developed selective differential medium, permits Campylobacter isolation without the need for microaerophilic incubation. The medium is supplemented with antibiotics to allow Campylobacter isolation in complex matrices such as human feces. The present study aims to evaluate the ability of the medium to recover Campylobacter from routine clinical samples. A total of 191 human stool samples were used to compare the ability of CAMPYAIR (aerobic incubation) and a commercial Campylobacter medium (CASA, microaerophilic incubation) to recover Campylobacter. All Campylobacter isolates were then identified by MALDI-TOF MS. CAMPYAIR showed sensitivity and specificity values of 87.5% (95% CI 47.4%–99.7%) and 100% (95% CI 98%–100%), respectively. The positive predictive value of CAMPYAIR was 100% and its negative predictive value was 99.5% (95% CI 96.7%–99.9%); Kappa Cohen coefficient was 0.93 (95% CI 0.79–1.0). The high diagnostic performance and low technical requirements of the CAMPYAIR medium could permit Campylobacter culture in countries with limited resources.

View
No Thumbnail Available
Publication

Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis

2018 , Luis Collado , Nataly Muñoz , Lorena Porte , Sofía Ochoa , Carmen Varela , Ivo Muñoz

View
No Thumbnail Available
Publication

Ghost tablets mimicking intestinal parasite

2019 , Lorena Porte , Thomas Weitzel

View
No Thumbnail Available
Publication

Genomic Analysis of Chilean Strains of Campylobacter jejuni from Human Faeces

2019 , Arturo Levican , Ignacio Ramos-Tapia , Isabel Briceño , Francisco Guerra , Benjamin Mena , Carmen Varela , PORTE TORRE, LORENA ISABEL

Campylobacterspp., especiallyC. jejuni, are recognized worldwide as the bacterial species that most commonly cause food-related diarrhea.C. jejunipossesses many different virulence factors, has the ability to survive in different reservoirs, and has shown among isolates the emergence of Antimicrobial Resistance (AMR). Genome association analyses of this bacterial pathogen have contributed to a better understanding of its pathogenic and AMR associated determinants. However, the epidemiological information of these bacteria in Latin American countries is scarce and no genomic information is available in public databases from isolates in these countries. Considering this, the present study is aimed to describe the genomic traits from representativeCampylobacterspp. strains recovered from faecal samples of patients with acute diarrhoea from Valparaíso, Chile.Campylobacterspp. was detected from the faeces of 28 (8%) out of 350 patients with acute diarrhoea, mainly from young adults and children, and 26 (93%) of the isolates corresponded toC. jejuni. 63% of the isolates were resistant to ciprofloxacin, 25.9% to tetracycline, and 3.5% to erythromycin. Three isolates were selected for WGS on the basis of theirflaA-RFLP genotype. They belonged to the multilocus sequence typing (MLST) clonal clomplex (CC) 21(PUCV-1), CC-48 (PUCV-3), and CC-353 (PUCV-2) and presented several putative virulence genes, including the Type IV and Type VI Secretion Systems, as well as AMR-associated genes in agreement with their susceptibility pattern. On the basis of the wgMLST, they were linked to strains from poultry and ruminants. These are the first genomes of ChileanC. jejuniisolates available in public databases and they provide relevant information about theC. jejuniisolates associated with human infection in this country.

View
No Thumbnail Available
Publication

Draft Whole-Genome Sequences of 51 Campylobacter jejuni and 12 Campylobacter coli Clinical Isolates from Chile

2020 , Verónica Bravo , Carmen Varela , PORTE TORRE, LORENA ISABEL , WEITZEL, THOMAS , George J. Kastanis , Maria Balkey , Carlos J. Blondel , Narjol Gonzalez-Escalona , David Rasko

Campylobacter species are the leading cause of gastroenteritis worldwide and an emerging threat in developing countries. Here, we report the draft whole-genome sequences of 51 Campylobacter jejuni and 12 Campylobacter coli strains isolated from patients with gastroenteritis in Santiago, Chile.

View